Showing posts with label MAY. Show all posts
Showing posts with label MAY. Show all posts

Tuesday, August 15, 2017

CERTAIN GUT BACTERIA MAY INDUCE METABOLIC CHANGES FOLLOWING EXPOSURE TO ARTIFICIAL SWEETENERS TNERESW





Artificial sweeteners -- promoted as aids to weight loss and diabetes prevention -- could actually hasten the development of glucose intolerance and metabolic disease, and they do so in a surprising way: by changing the composition and function of the gut microbiota -- the substantial population of bacteria residing in our intestines. These findings, the results of experiments in mice and humans, were published September 17 in Nature. Dr. Eran Elinav of the Weizmann Institute of Science's Department of Immunology, who led this research together with Prof. Eran Segal of the Department of Computer Science and Applied Mathematics, says that the widespread use of artificial sweeteners in drinks and food, among other things, may be contributing to the obesity and diabetes epidemic that is sweeping much of the world

For years, researchers have been puzzling over the fact that non-caloric artificial sweeteners do not seem to assist in weight loss, with some studies suggesting that they may even have an opposite effect. Graduate student Jotham Suez in Dr. Elinav's lab, who led the study, collaborated with lab member Gili Zilberman-Shapira and graduate students Tal Korem and David Zeevi in Prof. Segal's lab to discover that artificial sweeteners, even though they do not contain sugar, nonetheless have a direct effect on the body's ability to utilize glucose. Glucose intolerance -- generally thought to occur when the body cannot cope with large amounts of sugar in the diet -- is the first step on the path to metabolic syndrome and adult-onset diabetes.

The scientists gave mice water laced with the three most commonly used artificial sweeteners, in amounts equivalent to those permitted by the U.S. Food and Drug Administration (FDA). These mice developed glucose intolerance, as compared to mice that drank water, or even sugar water. Repeating the experiment with different types of mice and different doses of the artificial sweeteners produced the same results -- these substances were somehow inducing glucose intolerance.

Next, the researchers investigated a hypothesis that the gut microbiota are involved in this phenomenon. They thought the bacteria might do this by reacting to new substances like artificial sweeteners, which the body itself may not recognize as "food." Indeed, artificial sweeteners are not absorbed in the gastrointestinal tract, but in passing through they encounter trillions of the bacteria in the gut microbiota.
The researchers treated mice with antibiotics to eradicate many of their gut bacteria; this resulted in a full reversal of the artificial sweeteners' effects on glucose metabolism. Next, they transferred the microbiota from mice that consumed artificial sweeteners to "germ-free," or sterile, mice -- resulting in a complete transmission of the glucose intolerance into the recipient mice. This, in itself, was conclusive proof that changes to the gut bacteria are directly responsible for the harmful effects to their host's metabolism. The group even found that incubating the microbiota outside the body, together with artificial sweeteners, was sufficient to induce glucose intolerance in the sterile mice. A detailed characterization of the microbiota in these mice revealed profound changes to their bacterial populations, including new microbial functions that are known to infer a propensity to obesity, diabetes, and complications of these problems in both mice and humans.

Does the human microbiome function in the same way? Dr. Elinav and Prof. Segal had a means to test this as well. As a first step, they looked at data collected from their Personalized Nutrition Project ,the largest human trial to date to look at the connection between nutrition and microbiota. Here, they uncovered a significant association between self-reported consumption of artificial sweeteners, personal configurations of gut bacteria, and the propensity for glucose intolerance. They next conducted a controlled experiment, asking a group of volunteers who did not generally eat or drink artificially sweetened foods to consume them for a week, and then undergo tests of their glucose levels and gut microbiota compositions.

The findings showed that many -- but not all -- of the volunteers had begun to develop glucose intolerance after just one week of artificial sweetener consumption. The composition of their gut microbiota explained the difference: the researchers discovered two different populations of human gut bacteria -- one that induced glucose intolerance when exposed to the sweeteners, and one that had no effect either way. Dr. Elinav believes that certain bacteria in the guts of those who developed glucose intolerance reacted to the chemical sweeteners by secreting substances that then provoked an inflammatory response similar to sugar overdose, promoting changes in the body's ability to utilize sugar.
Prof. Segal states, "The results of our experiments highlight the importance of personalized medicine and nutrition to our overall health. We believe that an integrated analysis of individualized 'big data' from our genome, microbiome, and dietary habits could transform our ability to understand how foods and nutritional supplements affect a person's health and risk of disease."

According to Dr. Elinav, "Our relationship with our own individual mix of gut bacteria is a huge factor in determining how the food we eat affects us. Especially intriguing is the link between use of artificial sweeteners -- through the bacteria in our guts -- to a tendency to develop the very disorders they were designed to prevent; this calls for reassessment of today's massive, unsupervised consumption of these substances."



Friday, July 14, 2017

Guru Is A Scary Word But Janice Wiesman May Just Be A Neuropathy Guru!


Today's post from practicalneurology.com (see link below) may seem to have a slightly uninspiring title but trust me, this is an article which fills a glaring gap in internet information, in that it's addressed towards neuropathy patients directly and talks to us as if we are part of the process and not just a footnote at the end of a complex disease. Please read this because you will find your own neuropathy reflected here and may realise that what Janice Wiesman says is true...if science is currently failing neuropathy patients, then we have to empower ourselves to make the best improvements we can in our daily lives. The pay off is not a cure, or even a dazzling new medication but its an almost guaranteed improvement (however small) in our symptoms - most of you will pay good money for that!


Peripheral Neuropathy: Keys to Diagnosis, Management, and Patient Communication
By Janice Wiesman, MD October 2016

 Empowering patients to make lifestyle changes plays an essential role in managing peripheral neuropathy.
  

An estimated 20 million people in the US have peripheral neuropathy. That is one in 15 persons. Patients presenting with symptoms referable to the peripheral nerves—which include numbness, pain, paresthesia, and weakness— are common in neurology practice. And yet, residency programs are skewed towards the diagnosis and management of inpatient neurological disorders, which means that practicing neurologists may not become comfortable with diagnosing and treating neuropathy until early in the course of practice.

This article provides an overview of neuropathy diagnosis and management. It will also offer strategies for talking to patients about the disease and avenues for addressing it therapeutically.


Making the Diagnosis

Neuropathy itself is not usually a disease but a symptom of an underlying illness. The most common cause is diabetes mellitus. Heavy alcohol use and inherited forms also top the list. Medication-associated neuropathy may be overlooked. When we speak of inherited neuropathies we must distinguish between neuropathy that is inherited as a disease unto itself, such as Hereditary Motor and Sensory Neuropathy, versus inherited illness that has neuropathy as a symptom, such as familial amyloidosis or Pompe’s disease.

In unpacking the word “neuropathy” we recognize that this word can mean a lesion of a single nerve (mononeuropathy), multiple nerves scattered throughout the body that are affected at different times (mononeuropathy multiplex), or a disease of all nerves (peripheral neuropathy, also called polyneuropathy or simply neuropathy). Within the diagnosis of peripheral neuropathy there are three types: axonal, demyelinating, and dysmyelinative (which describes inherited disorders of myelin). Demyelinating neuropathies account for approximately 10 percent of all acquired neuropathies. The most common type is axonal, length-dependent, dying back polyneuropathy, which account for almost 90 percent of acquired neuropathies.

Sensory symptoms that patients describe with axonal neuropathy can range from a feeling as if bugs are crawling on their skin to shooting, electrical, or burning pains. When autonomic nerves are involved, common symptoms include lightheadedness when standing or sitting up, dry eyes and mouth, diarrhea, difficulty with vision and, in men, erectile dysfunction.

On examination, characteristic findings include symmetrically depressed or absent tendon reflexes at the ankles, atrophy of the extensor digitorum brevis, weakness of distal muscles in the legs and decreased or absent sensation in a stocking distribution. In most axonal neuropathies, small fiber modalities such as pain and cold sensation are affected first with large fiber modalities of vibration and joint position affected later. Careful examination of cranial nerve III may reveal a partial palsy associated with diabetes. With autonomic involvement, the skin over the legs may be shiny and dry with loss of hair distally. In patients whose symptoms are caused by vitamin B12 deficiency, the exam may instead show decreased large fiber sensation with preserved small fiber sensation and brisk, rather than depressed, reflexes. This is due to subacute combined degeneration of the spinal cord. Patients with this topsy-turvy exam in the face of symptoms suggestive of neuropathy should have a careful diet history taken and vitamin B12 level checked.

Evaluation of peripheral neuropathy includes testing of blood and urine, nerve conduction studies, and electromyography and lumbar puncture, if demyelinating neuropathy is suspected. Routine blood testing includes complete blood count, thyroid stimulating hormone, renal functions and tests for diabetes including hemoglobin A1c, fasting glucose and two-hour glucose tolerance test. Then, obtain serology for human immunodeficiency virus and hepatitis C. Depending on the patient’s history, you may also investigate less common causes, such as heavy metal exposure and inherited neuropathy. While you can test for syphilis, it is important to note that syphilis does not cause neuropathy. Tabes dorsalis can cause “lightening pains,” shooting into the legs and trouble with balance, but these symptoms are different from symptoms of neuropathy and I do not typically obtain this test.

Nerve conduction studies and electromyography can characterize neuropathy as axonal or demyelinating, sensory or motor or both and can give an idea as to the severity and chronicity of the neuropathy. In addition, it can exclude neuropathy look-a-likes such as lumbosacral radiculopathy. Nerve biopsy is typically not necessary except in cases where infiltration of the nerve (such as with lymphoma or amyloid) or vasculitis is suspected and treatment depends on a tissue diagnosis.


Treatment Options and Patient Communication

In the treatment phase, management of patients’ concerns is essential. Over the years I have found that patients think about treatment of neuropathy from three perspectives. These are expressed in the following questions: “Can I treat the cause of neuropathy?” “What can I do to help the nerves grow back?” “What can I do about the pain, tingling, weakness and autonomic symptoms?” After the history, examination and testing reveal the type of neuropathy, we still may not know the etiology but we can address the patients’ questions.

If the etiology is known, it can be addressed: for example, with better glucose control, treatment of hepatitis C, Vitamin B12 repletion and cutting back or abstaining from alcohol. I like to use this time to empower patients to help themselves: In the case of heavy alcohol use or poorly controlled diabetes mellitus I tell the patients that they are fortunate in that the key to control of their neuropathy is already in their hands. While this may lead patients to think they are being blamed for their trouble, I never say this. I instead use the opportunity to partner with patients in improving their health. If the etiology is not known, I discuss this candidly and make a plan for a follow-up examination with repeated testing in the future. I take a few minutes to explain the anatomy of neuropathy and emphasize that there is no magic medicine or treatment to help the nerves repair more quickly. This is disappointing for patients but it leads to a discussion of what can be done, whether or not the cause of their neuropathy is known.

When discussing treatment of sensory symptoms, my first question is: “Do you need or want to be treated?” I explain that treatment is for symptoms only and will not help the nerves heal. I also emphasize that there is no treatment for numbness. For some patients, symptoms are mild and they prefer to stay away from medication. Others prefer to control their symptoms with occasional non-steroidal anti-inflammatory medication or over the counter topical treatments such as local anesthetic or capsaicin creams. For patients who are interested in treatments, I categorize these as: non-medication treatments, medications that are not pills and medications that are pills.

Non-medication treatments include use of a warm water vibrating foot bath for 15 minutes before bed. This may calm down the pain long enough to fall asleep. The theory is that the input from large fibers mediating vibration and pressure will block the input from small pain fibers at the level of the spinal cord. Some people get relief from wearing tight socks. Percutaneous nerve stimulation, done by a professional, may relieve pain temporarily, though there is conflicting evidence regarding the usefulness of transcutaneous nerve stimulation. I have been asked about oral and smoked marijuana. There is conflicting data about marijuana’s usefulness for neuropathic pain, while the side effects and legal restriction for both oral and smoked marijuana also complicate the discussion.

Medications that are not pills include local anesthetic applied as a cream, spray, or patch. These are not recommended for people with cardiac arrhythmias or seizures. Capsaicin cream can be effective, but requires three times daily use and is messy. Recent studies show that botulinum toxin injections into the foot may relieve neuropathic pain by blocking the release of Substance p and other factors from sensory nerves.

Oral medications fall into two main categories: anti-seizure and antidepressant. These may be used on- or off-label. The FDA has approved only two medications specifically for this use: pregabalin and duloxetine, however others such as gabapentin, amitriptyline, and nortriptyline are sometimes used. I do not recommend the use of sedatives, such as carisoprodol and methocarbamol, due to their lack of efficacy and potential for addiction.

What if none of these approaches provides relief? The use of opioid medication for neuropathic pain is controversial, and, in my opinion, should be handled by an expert. It is reasonable to refer the patient to a pain management specialist who is comfortable with intravenous pain medications and less frequently used oral agents.

Motor symptoms are less amenable to treatment. I explain to patients that muscles require nerve stimulation to stay healthy and suggest physical and occupational therapy to try to preserve strength, endurance and function.

Autonomic symptoms are sometimes the most serious impediment to the enjoyment of daily life. Orthostatic hypotension can lead to falls and broken bones, daily diarrhea limits socializing and travel, dry mouth can lead to dental decay and erectile dysfunction can lead to depression. Depending on how comfortable you are with the treatment of gastrointestinal, orthostatic, and sexual dysfunction, the neurologist can, at least, initiate treatment and refer to the appropriate specialist.

As with any illness for which there is no satisfactory treatment, neuropathy treatment scams run loose on the Internet. I encourage patients to bring to my attention items they have found online or through patient forums before they buy and use them. While transcutaneous nerve stimulation devices, anodyne light therapy and supplements have hopeful and encouraging descriptions and testimonials, there is no evidence that they are effective in reducing neuropathic pain. In addition, many supplements and vitamins are advertised for the treatment of neuropathic pain. I make it a point to tell my patients that supplements are not regulated by the FDA, therefore consumers have no idea what is actually in the bottle they buy. In addition, supplements may interfere with medications they are taking and may contain filler ingredients, such as ground walnut shells that may trigger allergies.


The Importance of Setting Expectations

As physicians we have certain expectations for the treatment of neuropathy—reducing or alleviating pain and maintaining function. However, patients may have different expectations and these may be greater or lesser than we imagine. When all is said and done, the patient and his family must live every day with the symptoms and disabilities of neuropathy. The most important aspect of the discussion comes after review of the diagnosis, etiology, and treatment. I like to start out by asking what improvements are most important to the patient: Does he seek better mobility and endurance, relief from pain or autonomic symptoms, avoidance of foot complications?

I emphasize what patients can do to feel better. Exercise, regardless of the degree of disability, is important. Some patients require a physical therapy evaluation prior to partaking in exercise due to other health problems but for those who do not require this, keeping active with walking, biking, formal exercise classes, sports (including swimming and dancing) is always worth encouraging. Some patients question whether exercise could further damage the nerves and I tell them that, on the contrary, exercise will not damage nerves and that nerve input to muscle is required to keep muscles healthy. Occupational therapy is useful for those with weakness or sensory loss in the hands and physical therapy with gait training is suggested for those with trouble walking.

I always speak with patients about foot care. In fact, this may be the most important lifestyle issue I address. If they cannot feel their feet, hot water, cuts, a rock in shoe or blister on the heel will not be felt and all can lead to infection. I advise patients to look under and between their toes every day, to keep feet well moisturized, wear proper fitting shoes with socks, not to go barefoot and, most important of all, to not cut their own toenails. I advise filing the nails or seeking professional nail care from a podiatrist or pedicurist. I say, many times a day, “I want you to have all ten toes, all the time.”

Other lifestyle suggestions include limiting alcohol and tobacco use, good blood glucose control, and healthy diet. Some patients argue that it is difficult to give up smoking, while others can be defensive about the quantity of alcohol they drink, but I implore them not to “kick your nerves when they are down.”

After discussing with patients their concerns, I bring up issues they may be thinking about but are not bringing forward. By this time, I have seen the patient a few times and we have gotten comfortable with each other. I can now ask if there are concerns around sexual function and prognosis. It can be a tricky discussion, and I find it best to speak with the patient alone, including the spouse later if the patient requests. Patients with preserved sexual function are often surprised and relieved to hear that neuropathy is no barrier to sexual activity. For those whose function is impaired I offer referral to a urologist. As for prognosis, this depends very much on the cause of neuropathy and I like to use this discussion as an opportunity to encourage patients to undertake lifestyle changes that may not only improve or stabilize their neuropathy but also improve their general health. There often comes the question: “Doctor, will I end up in wheelchair?” Every patient’s circumstance is different and predicating the future is tricky so I like to emphasize what can be done to avoid that fate while still being realistic.


Conclusion: Empowering Patients

Peripheral neuropathy affects many aspects of life. As physicians, we concentrate on diagnosis, treatment of etiology when possible, and treatment of sensory symptoms, but we must not forget to think about day-to-day life from the patient’s point of view. Empowering patients affected by neuropathy to make lifestyle changes that can improve their overall health and make their lives as normal as possible is something we can always do. n

Include the Patient in the Process

After history and examination, it is important to bring the patient into your thought process and include them in the treatment discussion. It’s important to share questions such as: Is this peripheral neuropathy or something else? Do the symptoms and exam lead to a diagnosis of something that looks like neuropathy but is not, such as lumbo-sacral radiculopathy or plexopathy, myopathy or even a disease of the central nervous system, like multiple sclerosis? If the diagnosis is peripheral neuropathy, is testing needed to determine if this is the correct diagnosis? Am I certain of the cause or is testing needed? Is treatment appropriate at this time and if so, what kind? Would medications or lifestyle modifications help? I encourage patients to make sure the doctor tells them what she is thinking–this should not be a secret!

While patients are typically not familiar with the anatomical structures known as nerves, I find they are very interested in knowing what is causing their symptoms and with a small investment in patient education, they are able to understand. Educating patients about their disease is not isolated to those with neuropathy and is important for a number of reasons:
There is personal dignity in understanding what is wrong with your own body and why.
It encourages patients to participate the diagnostic
process.
It empowers patients to participate in their treatment
It may inspire lifestyle changes that will improve overall health
It protects patients from dangerous treatments
It protects patient’s wallet from useless treatments

— Janice Wiesman, MD



Janice Wiesman, MD, FAAN, is the author of Peripheral Neuropathy: What It Is and What You Can Do To Feel Better, Johns Hopkins Press, 2016. Go to amazon.com/author/janicewiesman to purchase.

 
http://practicalneurology.com/2016/10/peripheral-neuropathy-keys-to-diagnosis-management-and-patient-communication/

Sunday, July 2, 2017

VITAMIN D MAY NOT LOWER SENIORS FALL RISK



 Taking vitamin D supplements does little to reduce seniors’ risk of falls, a new review finds.
Researchers analyzed 20 studies that included nearly 30,000 people and tested how vitamin D supplements affected fall risk.
The results showed that the supplements did not reduce falls by 15 percent or more, which means they had little effect, according to Mark Bolland of the University of Auckland in New Zealand, and colleagues.
They concluded that there is insufficient evidence to support recommending vitamin D to seniors to lower their risk of falls, and also said that current ongoing studies investigating this theory are unlikely to change the conclusion.
The study was published in the April 23 issue of The Lancet Diabetes and Endocrinology journal.
The researchers noted that current evidence does not show whether taking vitamin D supplements might reduce falls in particularly vulnerable older people, such as those who fall often. This is because most studies examine only the total number of falls among all participants, rather than the number of falls per person.
Until now, some evidence that vitamin D supplements might prevent falls has led certain health organizations to recommend the use of the supplements, the review authors noted.
“Whether a large trial is feasible in this vulnerable population remains to be established. Until then, we are left with uncertainty about the benefits of vitamin D supplementation for reduction in fall risk, particularly among vulnerable older people,” Clifford Rosen, of the Maine Medical Research Institute, and Christine Taylor, of the U.S. National Institutes of Health, wrote in an accompanying commentary.






Sunday, June 25, 2017

9 11 DUST CLOUD MAY HAVE CAUSED WIDESPREAD PREGNANCY ISSUES



Pregnant women living near the World Trade Center during 9/11 experienced higher-than-normal negative birth outcomes, according to a new working paper by Princeton University's Woodrow Wilson School of Public and International Affairs.

These mothers were more likely to give birth prematurely and deliver babies with low birth weights. Their babies -- especially baby boys -- were also more likely to be admitted to neonatal intensive care units after birth. The study, led by the Wilson School's Janet Currie and Hannes Schwandt, was released by the National Bureau of Labor Economics in August.

"Previous research into the health impacts of in utero exposure to the 9/11 dust cloud on birth outcomes has shown little evidence of consistent effects. This is a puzzle given that 9/11 was one of the worst environmental catastrophes to have ever befallen New York City," said Currie, Henry Putnam Professor of Economics and Public Affairs, director of the economics department and director of the Wilson School's Center for Health and Wellbeing. "Our work suggests a simple resolution of this puzzle, which is that the women who lived in neighborhoods exposed to the 9/11 dust cloud had very different experiences than women in other parts of New York City."

The collapse of the two towers created a zone of negative air pressure that pushed dust and smoke into the avenues surrounding the World Trade Center site. Other past studies have shown that environmental exposure to the World Trade Center dust cloud was associated with significant adverse effects on the health of adult community residents and emergency workers.

Using data on all births that were in utero on Sept. 11, 2001 in New York City and comparing those babies to their siblings, the researchers found that, for mothers in their first trimester during 9/11, exposure to this catastrophe more than doubled their chances of delivering a baby prematurely. Of the babies born, boys were more likely to have birth complications and very low birth weights. They were also more likely to be admitted to the NICU.

The neighborhoods most affected by the 9/11 dust cloud included Lower Manhattan, Battery Park City, SoHo, TriBeCa, Civic Center, Little Italy, Chinatown and the Lower East Side. Previous studies analyzing the aftermath of 9/11 on health failed to account for many women living in Lower Manhattan, who were generally less likely to have poor birth outcomes than women living in other neighborhoods.



Friday, June 9, 2017

DIETING YOUNG MAY LEAD TO POOR HEALTH OUTCOMES LATER


Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB) finds that the younger a woman is when she goes on her first diet, the more likely she is to experience several negative health outcomes later in life.

Dieting is very common among girls and young women; however, people often fail to consider the long-term consequences of weight-loss diets, particularly in those who begin dieting at a young age. A team led by Dr. Pamela Keel from Florida State University asked college women in 1982, 1992, 2002, and 2012 to report their dieting and weight history. The team then followed women 10-years later and examined the impact of dieting history on long-term health outcomes.

The younger a woman was when she started her first diet, the more likely she was to use extreme weight control behaviors like self-induced vomiting, misuse alcohol, and be overweight or obese when she reached her 30's.

While the cause of these outcomes is not determined here, discouraging weight loss diets in young girls may reduce risk for eating, alcohol, and weight-related problems in adulthood. Public health initiatives should promote behaviors that increase wellness in girls, such as increasing activity, decreasing leisure time watching TV and on computers, and consuming more fruits and vegetables. Such interventions may need to begin as early as elementary school to support girls as they enter puberty, a time when their bodies will naturally experience rapid growth, weight gain, and an increase in body fat.



Thursday, June 1, 2017

Lasers May Be Able To Repair Damaged Nerve Sheaths


Today's post from diabetesqld.org (see link below) is an article from an Australian website that reports on what could be the next big thing regarding neuropathy treatment. I know...I can hear you sighing...after so many 'next big things' that turn out to be false dawns, we tend to view new findings with some skepticism don't we? However, the science behind this one seems to be solid and although many more studies are needed (as always), the idea that non-invasive laser treatment may be able to repair damaged myelin sheaths (insulation around the nerves) is a very attractive one. Also encouraging; the Brazilian lab admits it doesn't know why this seems to work but they have some theories that time will either prove or disprove. It may be a question from a dumb onlooker but precisely where do you apply the laser treatment? The very nature of peripheral neuropathy means that the damaged nerves can be very hard to pin down and identify. Just because the pain is in the feet or hands, doesn't mean that the damage is there also. I guess we'll just have to wait and see but this is one of those research discoveries you hope will turn out to be true and workable for us long-term sufferers.

Neuropathic pain? Science says lasers can help.
31 March 2017 /


 Recent studies at the University of São Paulo's Biomedical Science Institute (ICB-USP) in Brazil shows low-level laser therapy to be a non-invasive and effective alternative for treating neuropathic pain, a chronic condition caused by nerve damage, spinal cord injury or diseases such as diabetes.

The treatment in a model of diabetic neuropathy, one of the most common chronic and incapacitating complications of diabetes, was tested. Neuropathic pain in diabetes occurs when the disease is not properly controlled and excessive amounts of blood sugar cause oxidation of the myelin sheath, damaging the structure of peripheral nerves. As well as causing pain, this degenerative process impairs communication among neurons and can even lead to amputation of the lower limbs.

"We tested laser therapy in different rat neuropathy models, and behavioral responses improved in all of them," Professor Marucia Chacur, the principal investigator, said. "One of the beneficial effects observed was myelin sheath recovery. The myelin sheath is a lipid layer that covers the axon and acts as electrical insulation to assist nerve impulse propagation."

With the aid of a transmission electron microscope, the researchers found that as diabetes progressed, the structure of the sciatic nerve's myelin sheath changed. After four sessions of the treatment, however, the myelin had almost completely recovered.

"The condition of the nerve practically returned to baseline levels after treatment. We're now continuing the study by analyzing protein expression and the release of inflammatory cytokines to understand exactly what's happening," Chacur said.

In a second study, treatment focused on the sciatic nerve, and found that astrocytes - star-shaped cells that play an active role in brain function and inflammatory responses - were the first type of cell to migrate to the site of a nerve injury or inflammatory process. These cells release several inflammatory mediators, which in turn trigger the release of other inflammatory substances.

"We believe the laser curtails this chain reaction as if it were anti-inflammatory medication, by reducing the migration of astrocytes to the site of the injury," Chacur said.

The third model used to test low-level laser therapy focused on orofacial pain, involving the inferior alveolar nerve, one of the branches of the trigeminal nerve responsible for innervating the face. Phototherapy started two days after injury and improvement was observed after two sessions.

"We set out to understand the mechanisms and mediators involved because we believed phototherapy could be used in association with pharmacological treatment because it acts via a different pathway. In this way, it may be possible to reduce the drug dose and mitigate the systemic effects of the treatment," Chacur said.

The results suggest that all three models of neuropathic pain studied share a common mechanism involving myelin sheath regeneration and reduced astrocyte migration to the site of the lesion, she added.

"Evidence in the literature also suggests an effect on mitochondria. The laser apparently facilitates the flow of calcium in these organelles, boosting production of ATP [adenosine triphosphate, the body's cellular fuel] and leading to enhanced healing as well as the release of mediators that assist remodeling. In future studies, we plan to investigate this effect on mitochondria more thoroughly," Chacur concluded.

http://www.diabetesqld.org.au/media-centre/2017/march/neuropathic-pain-science-says-lasers-can-help.aspx


Monday, May 15, 2017

CROHNS AND COLITIS MAY BE TIED TO RISK OF HEART ATTACK STROKE



People with inflammatory bowel disease may be at increased risk for heart attack and stroke, a new study suggests.
Researchers analyzed data from more than 150,000 inflammatory bowel disease (IBD) patients who took part in nine studies. They found that these patients had a 10 percent to 25 percent increased risk of stroke and heart attack, and that this increased risk was more prevalent among women.
Doctors need to be aware of this link and should focus on controlling other stroke and heart attack risk factors, such as smoking, high blood pressure and diabetes, study author Siddharth Singh, of the Mayo Clinic in Rochester, Minn., said in a news release from the clinic.
The study was scheduled for presentation Monday at the annual meeting of the American College of Gastroenterology, in San Diego. Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.
Crohn’s disease and ulcerative colitis — the most common forms of IBD — affect 1.5 million Americans. In these patients, inflammation of the intestine leads to rectal bleeding, diarrhea, abdominal cramps and pain, fever, and weight loss.
Patients with IBD need to work with a doctor to manage their condition, control their stress, eat a healthy diet and get moderate exercise. Smoking is a major risk factor for IBD patients, and those who smoke should try to quit, the researchers said.
Although the study found an association between IBD and an increased risk for heart attack and stroke, it did not prove a cause-and-effect relationship.
Bottom of Form
Bottom of Form


Saturday, May 6, 2017

BLOOD TEST MAY HELP DETERMINE WHO IS AT RISK FOR PSYCHOSIS



A study led by University of North Carolina at Chapel Hill researchers represents an important step forward in the accurate diagnosis of people who are experiencing the earliest stages of psychosis.

Psychosis includes hallucinations or delusions that define the development of severe mental disorders such as schizophrenia. Schizophrenia emerges in late adolescence and early adulthood and affects about 1 in every 100 people. In severe cases, the impact on a young person can be a life compromised, and the burden on family members can be almost as severe.
The study published in the journal Schizophrenia Bulletin reports preliminary results showing that a blood test, when used in psychiatric patients experiencing symptoms that are considered to be indicators of a high risk for psychosis, identifies those who later went on to develop psychosis.
"The blood test included a selection of 15 measures of immune and hormonal system imbalances as well as evidence of oxidative stress," said Diana O. Perkins, MD, MPH, professor of psychiatry in the UNC School of Medicine and corresponding author of the study. She is also medical director of UNC's Outreach and Support Intervention Services (OASIS) program for schizophrenia.
"While further research is required before this blood test could be clinically available, these results provide evidence regarding the fundamental nature of schizophrenia, and point towards novel pathways that could be targets for preventative interventions," Perkins said.
Clark D. Jeffries, PhD, bioinformatics scientist at the UNC-based Renaissance Computing Institute (RENCI), is a co-author of the study, which was conducted as part of the North American Prodrome Longitudinal Study (NAPLS), an international effort to understand risk factors and mechanisms for development of psychotic disorders.
"Modern, computer-based methods can readily discover seemingly clear patterns from nonsensical data," said Jeffries. "Added to that, scientific results from studies of complex disorders like schizophrenia can be confounded by many hidden dependencies. Thus, stringent testing is necessary to build a useful classifier. We did that."
The study concludes that the multiplex blood assay, if independently replicated and if integrated with studies of other classes of biomarkers, has the potential to be of high value in the clinical setting.



Wednesday, April 26, 2017

SUNSHINE MAY SLOW WEIGHT GAIN DIABETES ONSET


Exposure to moderate amounts of sunshine may slow the development of obesity and diabetes, a study suggests.
Scientists who looked at the effect of sunlight on mice say further research will be needed to confirm whether it has the same effect on people.
The researchers showed that shining UV light at overfed mice slowed their weight gain. The mice displayed fewer of the warning signs linked to diabetes, such as abnormal glucose levels and resistance to insulin.
The beneficial effects of UV treatment were linked to a compound called nitric oxide, which is released by the skin after exposure to sunlight. Applying a cream containing nitric oxide to the skin of the overfed mice had the same effect of curbing weight gain as exposure to UV light, the team found.
Vitamin D -- which is produced by the body in response to sunlight and often lauded for its health benefits -- did not play a role, the study found.
The team says the new findings add to the growing body of evidence that supports the health benefits of moderate exposure to the sun's rays.
Previous studies in people have shown that nitric oxide can lower blood pressure after exposure to UV lamps.
The results should be interpreted cautiously, the researchers say, as mice are nocturnal animals covered in fur and not usually exposed to much sunlight. Studies are needed to confirm whether sunshine exposure has the same effect on weight gain and risk of diabetes in people.
Researchers at the Telethon Kids Institute in Perth, Western Australia, led the study in collaboration with the Universities of Edinburgh and Southampton.
Dr Shelley Gorman, of the Telethon Kids Institute and lead author of the study, said: "Our findings are important as they suggest that casual skin exposure to sunlight, together with plenty of exercise and a healthy diet, may help prevent the development of obesity in children."
"These observations further indicate that the amounts of nitric oxide released from the skin may have beneficial effects not only on heart and blood vessels but also on the way our body regulates metabolism," Dr Martin Feelisch, Professor of Experimental Medicine and Integrative Biology at the University of Southampton, added.
Dr Richard Weller, Senior Lecturer in Dermatology at the University of Edinburgh, said: "We know from epidemiology studies that sun-seekers live longer than those who spend their lives in the shade. Studies such as this one are helping us to understand how the sun can be good for us. We need to remember that skin cancer is not the only disease that can kill us and should perhaps balance our advice on sun exposure."
The research is published in the journal Diabetes.